Arrowpoint Investment Partners’s Ventyx Biosciences VTYX Stock Holding History

Arrowpoint Investment Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,453	Closed	-$257K	–	140
2025 Q4	$257K	Buy	28,453 +1,595	+6%	+$11.9K	0.04%	92
2025 Q3	$83.5K	Buy	+26,858	New	+$71.2K	0.08%	73

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arrowpoint Investment Partners's VTYX Position: Q1 2026 in Review

Arrowpoint Investment Partners sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 28,453 shares — an estimated $257K sold.

Arrowpoint Investment Partners first reported a position in VTYX in Q3 2025 and held it in 2 quarters. The position peaked at $257K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Arrowpoint Investment Partners reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Arrowpoint Investment Partners sold 28,453 Ventyx Biosciences shares in Q1 2026, an estimated $257K.
Arrowpoint Investment Partners first reported a position in Ventyx Biosciences in Q3 2025 and held it in 2 quarters.
Arrowpoint Investment Partners's Ventyx Biosciences position peaked at $257K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.